Table 1 Antibacterial activity of biosynthesized silver nanoparticles using disc diffusion assay.
Bacterial strains | Zone of inhibition (mm) | |
|---|---|---|
BO-AgNP | Control | |
Bacteroides fragilis | 9.43 ± 0.40 | 9.56 ± 0.30 |
Streptococcus pneumoniae | 10.33 ± 0.57 | 11.00 ± 0.20 |
Staphylococcus aureus | 10.1 ± 0.17 | 10.78 ± 0.11 |
Klebsiella pneumoniae | 10.0 ± 0.50 | 11.00 ± 0.20 |
Escherichia coli | 10.0 ± 1.00 | 10.8 ± 0.50 |
Enterococcus faecalis | 11.16 ± 0.28 | 11.45 ± 0.15 |
Proteus mirabilis | 11.33 ± 0.57 | 12.00 ± 0.25 |
Pseudomonas aeruginosa | 12.0 ± 0.20 | 12.5 ± 0.15 |
Staphylococcus epidermidis | 14.33 ± 0.57 | 14.59 ± 0.67 |